Work

Race and ethnicity reporting by US federal standards in high-impact phase 2/3 oncology clinical trial publications.

Year: 2023

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2023.41.16_suppl.1595

Authors: Kekoa A. Taparra, Ryan Benevente, Jonathan Shih, Megan Y. Gimmen, Paul Tominez, Kāʻeo Kekumano, Eric Pineda, Recinda Sherman, Curtiland Deville, Jeffrey M. Peppercorn, Scarlett L. Gomez, Linda D. Bosserman, Fumiko Chino, Manali I. Patel, Chirag S. Shah

Institutions: Stanford Cancer Institute, Harvard University, University of California, San Francisco, Tulane University, North American Association of Central Cancer Registries, Johns Hopkins University, Massachusetts General Hospital, City Of Hope National Medical Center, Memorial Sloan Kettering Cancer Center, Stanford Medicine, Stanford University, Cleveland Clinic

Language: English

Topic: Race, Genetics, and Society

Subfield: Genetics

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDGs: Good health and well-being, Reduced inequalities

Open Access status: closed

OpenAlex ID: W4379328340

Cites:

Cited by: 1

Related to: 10